Author | Cesar Augusto Santa-Maria, MD


Obese Breast Cancer Patients and Survivors: Management Considerations

August 15, 2018

This article will present feasible weight loss interventions, and will discuss practical implications of ongoing chemotherapy and endocrine therapy with regard to weight gain, and the impact of obesity on therapy-related conditions during breast cancer survivorship.

Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here?

February 15, 2016

This review will summarize the current standard of care; key issues that arise when treating patients with HER2-positive disease; and developments in novel therapeutics, including small-molecule inhibitors, nanoparticles, immunotherapy, and agents targeting resistance pathways.

The Role of Ovarian Suppression in Premenopausal Women With Hormone Receptor–Positive Early-Stage Breast Cancer

July 15, 2015

Here, we provide an in-depth review of the current evidence for the addition of ovarian suppression to adjuvant endocrine therapy, and we offer recommendations for clinical management.